Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
21.75
+1.45 (7.14%)
Aug 15, 2025, 1:03 PM - Market open
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Total Products | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total Products Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EXONDYS 51 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| EXONDYS 51 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VYONDYS 53 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| VYONDYS 53 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration and Other | 114.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration and Other Growth | 161.34% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMONDYS 45 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| AMONDYS 45 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ELEVIDYS | 820.79M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| ELEVIDYS Growth | 167.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Total PMO Products | 967.17M |
Log In |
Log In |
Log In |
Log In | Upgrade
|